Search LUCY
Innovative Eyewear Inc
Nasdaq, Nasdaq · CIK 1808377
Last close0.89
Daily change-0.03 (-3.15%)
10 Years gain-99.24%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
LUCY · STANDARD
SIC 3851 · Ophthalmic Goods · Fiscal year end 1231
Fundamental
63.6Momentum
n/aAcceleration
n/aConfidence
60.0Annual Revenue5
Quarterly Revenue18
Annual CFO5
Balance SheetAvailable
RankingLimited
Score Breakdown
Growth25.0 / 25
Quality13.6 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics10.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 3.6652 percentage points.
Heavy share dilution · HIGHDiluted share count increased 161.0711%.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM77.54%OK
Revenue CAGR 3Y59.19%OK
Gross Margin21.45%OK
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y161.07%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $2.66M | $567,451.00 | n/a | -$7.28M | -$7.35M | 21.32% | n/a | -276.06% | n/a | 3.99M |
| 2025 FY Dec 31, 2024 | $1.64M | $215,190.00 | n/a | -$6.74M | -$6.80M | 13.15% | n/a | -415.65% | n/a | 1.5M |
| 2024 FY Dec 31, 2023 | $1.15M | -$119,329.00 | n/a | -$5.77M | -$5.84M | -10.35% | n/a | -507.15% | n/a | 613,000 |
| 2023 FY Dec 31, 2022 | $659,788.00 | -$56,289.00 | n/a | -$3.22M | -$3.35M | -8.53% | n/a | -507.13% | n/a | 6.53M |
| 2022 FY Dec 31, 2021 | $690,670.00 | $148,254.00 | n/a | -$1.21M | -$1.23M | 21.47% | n/a | -178.8% | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $3.03M | sum latest 4 fiscal quarters Revenue | OK | 0001829126-26-008847, 0001829126-25-009128 |
| Revenue Growth TTM | 77.54% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001829126-26-008847, 0001829126-25-009128 |
| Revenue CAGR 3Y | 59.19% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001829126-26-002695 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001829126-26-002695 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001829126-26-002695 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 21.45% | Gross Profit / Revenue | OK | 0001829126-26-008847, 0001829126-25-009128 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001829126-26-008847 |
| Current Ratio | 12.06x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.47 | Revenue / Diluted Shares | OK | 0001829126-26-008847, 0001829126-25-009128 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001829126-26-002695 |
| Diluted EPS TTM | -$1.24 | Net income TTM / Diluted shares | OK | 0001829126-26-008847, 0001829126-25-009128 |